Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery

Significant post-operative bleeding can be encountered in a small population of pediatric surgical patients requiring cardiopulmonary bypass (CPB). Recombinant factor VIIa (Novo-Seven) has been advocated as a possible off-label rescue therapy for these individuals when conventional blood component t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Extra Corpor Technol
Autores principales: Niles, Scott D., Burkhart, Harold M., Duffey, David A., Buhrman, Keri, Burzynski, Jeffrey, Holt, David W.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of ExtraCorporeal Technology 2008
Materias:
Abstract
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4680713/
https://ncbi.nlm.nih.gov/pubmed/19192753
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares